Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
RXI PHARMACEUTICALS CORP NEW
CUSIP: 74979C808
Class: COM
UBS Group AG's Holding History (CIK: 0001610520)
Note: Option positions (PUT/CALL) are excluded.
Q3 2018
Shares
1,181
Value ($000)
$1
Avg Close
—
Range
—
Q2 2018
Shares
1,356
Value ($000)
$3
Avg Close
—
Range
—
Q1 2018
Shares
3,862
Value ($000)
$12
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2018
1,181
$1
—
—
Q2 2018
1,356
$3
—
—
Q1 2018
3,862
$12
—
—